The chronic obstructive pulmonary disease (COPD) market has seen significant expansion recently in the United States, largely as a result of the rising number of both current and former smokers.

Patient non-compliance remains a critical issue as current treatment options can be complicated or inconsistently maintained throughout treatment cycle. Insurance coverage can also vary depending on treatment type.

Growth in the boomer and elderly segments of the population as well as increased screening for the disease are also contributing factors for the increase in patient population.